Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 7/20 | 1.00 |
| ▸ | MIF | P14174 | 5/20 | 1.00 |
| ▸ | MAOA | P21397 | 4/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.76 |
| ▸ | TNF | P01375 | 2/20 | 0.76 |
| ▸ | MAPT | P10636 | 2/20 | 0.68 |
| ▸ | ACHE | P22303 | 3/20 | 0.67 |
| ▸ | BCHE | P06276 | 1/20 | 0.67 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.66 |
| ▸ | STK17B | O94768 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3694617 | 1.00 | MAOB (1.00) | MAOBMIFMAOACYP19A1TNF | |
| SCHEMBL3700238 | 1.00 | MAOB (1.00) | MAOBMIFMAOACYP19A1TNF | |
| SCHEMBL30462578 | 1.00 | MAOB (1.00) | MAOBMIFMAOACYP19A1TNF | |
| SCHEMBL30462577 | 1.00 | MAOB (1.00) | MAOBMIFMAOACYP19A1TNF | |
| SCHEMBL30977980 | 1.00 | MAOB (1.00) | MAOBMIFMAOACYP19A1TNF | |
| SCHEMBL14033556 | 0.89 | MIF (0.81) | MAOBMIFMAOACYP19A1TNF | |
| SCHEMBL27560521 | 0.88 | MAOB (0.86) | MAOBMIFMAOACYP19A1TNF | |
| SCHEMBL6967940 | 0.86 | MAOB (0.76) | MAOBMIFMAOACYP19A1TNF | |
| SCHEMBL7701204 | 0.86 | MIF (1.00) | MAOBMIFMAOACYP19A1TNF | |
| SCHEMBL15489882 | 0.86 | MAOB (0.76) | MAOBMIFMAOACYP19A1TNF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121586757-A | Half wave plate | 默克专利股份有限公司 | 2026-02-27 | — | — | CN | claimed |
| CN-116283657-A | Indenone derivative and synthetic method and application thereof | 贵州大学 | 2023-06-23 | — | — | CN | claimed |
| CN-108516929-B | 2-methylene- (3-methoxy-4-hydroxy) -benzyl-1-indanone analogue and application thereof | 温州医科大学 | 2021-06-18 | — | — | CN | claimed |
| CN-108164409-B | 2-benzylidene-1-indanone analogue and application thereof | 温州医科大学 | 2021-06-18 | — | — | CN | claimed |
| US-7166274-B2 | Synergistically high SPF photoprotective UV-screening compositions comprising insoluble organic sunscreen particles/diarylbutadiene compounds | L'OREAL (FR) | 2007-01-23 | — | — | US | claimed |
| US-20040047820-A1 | Synergistically high SPF photoprotective UV-screening compositions comprising insoluble organic sunscreen particles/diarylbutadiene compounds | SOCIETE L'OREAL S.A. (FR) | 2004-03-11 | — | — | US | claimed |
| EP-1370232-A2 | COSMETIC SOLAR PROTECTION COMPOSITIONS BASED ON A SYNERGIC MIXTURE OF FILTERS AND USES | L'OREAL (FR) | 2003-12-17 | — | — | EP | claimed |
| US-6627180-B2 | Particles having protection factor UV-APPD and an amino substituted 2-hydroxybenzophenone | SOCIETE L'OREAL S.A. (FR) | 2003-09-30 | — | — | US | claimed |
| US-20030152532-A1 | SYNERGISTICALLY UV-PHOTOPROTECTING COMPOSITIONS COMPRISING MIXED SCREENING AGENTS | SOCIETE L'OREAL S.A. (FR) | 2003-08-14 | — | — | US | claimed |
| EP-1317918-A1 | Cosmetic sunscreen compositions based on synergistic filter mixture and their use | L'OREAL (FR) | 2003-06-11 | — | — | EP | claimed |
| WO-2002056858-A1 | SOLAR PROTECTION COMPOSITIONS | L'OREAL (FR) | 2002-07-25 | — | — | WO | claimed |
| WO-2002049597-A2 | COSMETIC SOLAR PROTECTION COMPOSITIONS BASED ON A SYNERGIC MIXTURE OF FILTERS AND USES | L'OREAL (FR) | 2002-06-27 | — | — | WO | claimed |
| EP-4731727-A1 | HALF-WAVE PLATE | Merck Patent GmbH (DE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4713414-A1 | OPTICAL ELEMENT COMPRISING A CHIRAL LC POLYMER FILM | Merck Patent GmbH (DE) | 2026-03-25 | — | — | EP | disclosed |
| CN-121586757-A | Half wave plate | 默克专利股份有限公司 | 2026-02-27 | — | — | CN | disclosed |
| EP-4689002-A1 | REACTIVE MESOGENS WITH HIGH BIREFRINGENCE | Merck Patent GmbH (DE) | 2026-02-11 | — | — | EP | disclosed |
| US-4038274-A | ANTIDEPRESSANTS | E. R. SQUIBB & SONS, INC. (US) | 1977-07-26 | — | — | US | disclosed |
| US-3995052-A | Indenopyran- and indenothiopyranalkylamines III in the treatment of depression | AYERST MCKENNA AND HARRISON LTD. (CA) | 1976-11-30 | — | — | US | disclosed |
| US-3983288-A | Fibers and fabrics containing optical brightening agents | EASTMAN KODAK COMPANY (US) | 1976-09-28 | — | — | US | disclosed |
| US-3969527-A | INDENO(1,2-C)PYRAZOLE | E. R. SQUIBB & SONS, INC. (US) | 1976-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040047820-A1 | Synergistically high SPF photoprotective UV-screening compositions comprising insoluble organic sunscreen particles/diarylbutadiene compounds | SUCLG1, CUTA, DLD | MAOB 1776/4885MIF 3072/4885MAOA 2132/4885 |
| US-20030152532-A1 | SYNERGISTICALLY UV-PHOTOPROTECTING COMPOSITIONS COMPRISING MIXED SCREENING AGENTS | HADHB, SDHA, ERCC4 | MAOB 1274/4885MIF 2357/4885MAOA 1696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.